Mixed options sentiment in Novo Nordisk (NVO), with shares up 92c, or 1.79%, near $52.53. Options volume running well above average with 139k contracts traded and calls leading puts for a put/call ratio of 0.37, compared to a typical level near 0.49. Implied volatility (IV30) dropped 0.4 near 37.68,in the bottom quartile of the past year, suggesting an expected daily move of $1.25. Put-call skew steepened, indicating increased demand for downside protection.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
- Novo Nordisk Expands Cardiovascular Ambitions With New Phase 3 Ziltivekimab Plaque Study
- Unusually active option classes on open December 24th
- Novo, Lilly race to cement lead in India’s obesity drug market, Reuters says
- KeyBanc sees West, Stevanato ramping despite oral Wegovy approval